oaioai:figshare.com:article/1299626

T cell responses induced by tested vaccine candidates.

Abstract

<p>(A) Mice (<i>n</i> = 3 per group) were immunized once with 5 μg of DREP-C-ENV or 5 μg of DREP-C-GPN alone, or both constructs either mixed or given at separate sites. DREP constructs were given i.d. followed by EP. Splenocytes were assayed 10 days post-immunization with IFN-γ Elispot using peptides PADPNQEM (Env), VGPTPVNI (Pol1) and YYDPSKDLI (Pol2). (B-D) DREP-C-ENV and DREP-C-GPN induce T cells and antibodies that are boosted by multiple administrations. Mice (<i>n</i> = 5 per group) were immunized by i.d. EP one to three times with 5 or 0.1 μg of each DREP-C-ENV and DREP-C-GPN given at separate sites. One group was given DNA-C (5 μg of each construct) 3 times i.m. Boost immunizations were given with a 3 week interval between each administration. (B) Serum was assayed with ELISA for anti-gp140 IgG antibodies 3 weeks after the last immunization. Responses are shown as box plots, with whiskers representing 5–95 percentiles. (C) Splenocytes were assayed with IFN-γ Elispot 10 days and 3 weeks after last immunization using the peptides described above. (D) ICS for CD107a, IFN-γ, IL-2 and TNF-α was performed on splenocytes 10 days after the last immunization. The percentage of CD8+ T cells expressing a certain number of cytokines is shown. Specific markers expressed are shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0117042#pone.0117042.s002" target="_blank">S2 Fig.</a> Statistical analyses were performed to compare mice given a different number of administrations of the same dose of DREP-C. In addition, mice given the same number of administrations but with different doses/regimens were compared in separate statistical comparisons. Abbreviations: D-ENV, DREP-C-CN54ENV; D-GPN, DREP-C-ZM96GPN. * <i>P</i> < 0.05; ** <i>P</i> < 0.01</p

Similar works

Full text

thumbnail-image
oaioai:figshare.com:article/1299626Last time updated on 2/12/2018

This paper was published in FigShare.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.